Meso Scale Discovery (MSD) is committed to supporting research studies with bioanalytical tools that can precisely measure biomarkers, including phosphoproteins, cytokines, and other disease-specific biomarkers. MSD assay services offer assay development and optimization for bioanalytical assays such as MSD cytokine multiplex biomarker analysis, personalized training, and instrument service packages to not only support your research studies but also accelerate experimental results. Besides, MSD assay services have a team of scientists and specialists to support research goals and provide high-quality bioanalytical solutions. The current article focuses on services such as MSD cytokine assays for biomarker testing.
MSD assay services for custom biomarker tests
MSD assay services offer numerous MSD multiplex ELISA assays to screen and validate custom biomarkers. With more than 20 years of experience delivering high-quality MSD analysis, Meso Scale Discovery can help accelerate your biomarker from early-stage discovery studies to completely validated bioanalytical ELISA development. MSD assay services support a broad range of biomarkers that can be screened and eventually translated into focused panels to support your testing needs.
MSD assay services have a specific set of assays-, S-plex systems, that can deliver femtogram per ml sensitivity with reliability and precision. S-plex assays are critical for clients requiring more sensitive assays for biomarker testing. This assay system can detect and quantify biomarkers in very low abundance and instill confidence that the analyte measured is the biomarker of interest. Moreover, they have experts who can help clients understand their research needs and develop a tailored plan specific to those sample testing needs.
Today, clinical sciences require high-quality assays to guide drug development decisions. However, developing robust and reliable assays can be challenging. MSD assay services offer streamlined processes to develop high-quality bioanalytical assays for all research needs. They have documented success in collaboration with top pharmaceutical and drug development companies for developing bioanalytical assays for a wide range of clinical and drug development applications.
MSD assay services for biomarker testing follow a rigid and regulated process. The first feasibility step initiates a proof of concept and helps researchers select the initial antibodies and other assay performance criteria. In the development and verification process, MSD assay services develop a bioanalytical assay and tests for dynamic range, limits of detection, sample evaluation, and other multiplex optimization features. Finally, during validating biomarker assays, MSD ensures that the bioanalytical method is validated to support its intended applications.
MSD assay services offer custom conjugation solutions for conjugating biomolecules with Sulfo-tag or biotin labels on their platform. Sulfo-labels serve as detectors, whereas biotin-conjugated biomolecules can be used as capture or detection material. Besides, MSD assay services have standard conjugation solutions for proteins, peptides, antibodies, and oligonucleotides.
Additionally, MSD assay services have a specific gold conjugation solution for antibodies. This service includes standard conjugation services, quality assessments and characterization features of the conjugated product. These gold-standard conjugation services are crucial for clients performing longitudinal studies or validated protocols that require reproducibility and excellent performance.
Read Blog : MSD Biomarker Analysis: A Powerful Tool for Biomarker Detection
